Merck held talks to buy biotech MoonLake for over US$3 billion: FT
Published Tue, Jun 3, 2025 · 07:45 AMMERCK has held talks to buy Swiss biotech MoonLake Immunotherapeutics for more than ...
Tag: Merck
China’s WuXi Biologics to sell vaccine facility to Merck for US$500 million
WUXI Biologics Cayman will sell a vaccine facility in Ireland to Merck for about US$500 million as the Chinese company ...
Merck snags Chinese obesity drug in nearly US$2 billion deal
MERCK snagged a potential drug in the burgeoning market for obesity medications in a deal worth as much as US$2 ...
Merck snags Chinese cancer drug for up to US$3.3 billion
MERCK & Co licenced an experimental cancer antibody from a closely held Chinese company in a deal worth US$588 million ...
Merck narrows sales outlook with Gardasil lagging in China
MERCK lowered the top end of its full-year sales guidance after demand for its HPV vaccine fell for a second ...
Germany’s Merck open to more M&A for its Life Science division
GERMAN science and technology group Merck is open to more acquisitions for its Life Science business after announcing in May ...
Merck cuts annual profit forecast
Merck on Tuesday (Jul 30) cut its full-year earnings forecast, mainly due to one-time charges from its acquisition of eye-focused ...
Forbes 40under40 stands as a distinguished platform revered for its commitment to honoring and applauding the remarkable achievements of exceptional individuals who have yet to reach the age of 40. This esteemed initiative serves as a beacon of inspiration, spotlighting trailblazers across various industries and domains, showcasing their innovation, leadership, and impact on a global scale.
© 2024 Forbes 40under40. All Rights Reserved.